Waters and DAISO have jointly announced that they are entering into a collaborative agreement to globally market and supply DAISOGEL bulk packing materials for process chromatography.
Waters and DAISO have jointly announced that they are entering into a collaborative agreement to globally market and supply DAISOGEL bulk packing materials for process chromatography.
According to a statement from the companies, the combined purification expertise of both organizations will aid pharmaceutical and biopharmaceutical companies as they move from lab-scale purifications into pilot plant and process-scale manufacturing.
To simplify scaling-up purification methods, DAISOGEL columns are packed using Waters patented Optimum Bed Density (OBD) technology. Waters claims OBD technology enables analytical column performance and longer lifetimes in larger preparative columns.
DAISO’s quality control system is reported to be based on ISO 9001 and has met the quality requirements of global pharmaceutical companies. DAISO also has a DMF (Drug Master File) with the US Food and Drug Administration for the DAISOGEL packing materials.
For more information go to www.waters.com/purification and www.daiso-co.com/eng
LC–MS/MS-Based System Used to Profile Ceramide Reactions to Diseases
April 26th 2024Scientists from the University of Córdoba in Córdoba, Spain recently used liquid chromatography–tandem mass spectrometry (LC–MS/MS) to comprehensively profile human ceramides to determine their reactions to diseases.
High-Throughput 4D TIMS Method Accelerates Lipidomics Analysis
April 25th 2024Ultrahigh-pressure liquid chromatography coupled to high-resolution mass spectrometry (UHPLC-HRMS) had been previously proposed for untargeted lipidomics analysis, but this updated approach was reported by the authors to reduce run time to 4 min.